封面
市场调查报告书
商品编码
1709464

医药分析测试外包市场,按服务类型、按测试类型、按最终用户、按国家和地区划分 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, By Testing Type, By End-User, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年,医药分析测试外包市场规模价值 85.3055 亿美元,2025 年至 2032 年的复合年增长率为 7.70%。

医药分析测试外包市场-市场动态

仿製药市场的扩张推动了分析测试需求

仿製药市场的扩张是推动医药分析测试外包市场发展的重要动力。随着全球(尤其是北美)对平价药物的需求不断增长,製药公司越来越注重开发仿製药,这需要严格的分析测试以确保品质和法规遵循。仿製药行业受益于较低的生产成本,而外包分析测试可以让公司在控制费用的同时保持高标准。此外,将仿製药快速推向市场的压力越来越大,进一步推动了外包的需求,因为第三方测试提供者可以提供速度和专业知识。根据美国 FDA 统计,美国超过 90% 的处方药都是仿製药,凸显了庞大的市场规模以及对可靠、高效检测的需求。预计这一趋势将持续下去,并在未来几年推动对合约测试服务的需求。

医药分析测试外包市场-关键见解

根据我们的研究分析师的分析,预计全球市场在预测期内(2025-2032 年)的年复合成长率约为 7.70%。

根据服务类型细分,预计品质控制测试将在 2024 年占据最大市场份额

根据测试类型细分,成品测试是 2024 年领先的测试类型

根据最终用户细分,製药公司是 2024 年领先的最终用户

按地区划分,北美是 2024 年的主要收入来源

医药分析测试外包市场-細項分析:

全球製药分析测试外包市场根据服务类型、测试类型、最终用户和地区进行细分。

根据服务类型,市场分为六类:品质控制测试、生物分析测试、稳定性测试、方法开发和验证、监管测试和微生物测试。在製药分析测试外包市场中,品质控制测试是最重要且最主要的部分。这是因为它在确保药品在进入市场之前符合所需的安全性、有效性和品质标准方面发挥关键作用。品质控制测试在整个药物开发过程中是强制性的,对于遵守法规至关重要,这使其成为製药业外包的重点。对高品质、可靠产品的需求不断增长,推动了对这些服务的持续需求,进一步巩固了其突出地位。

根据测试类型,市场分为四大类:原料测试、成品测试、临床试验测试和包装测试。在医药分析测试外包市场的测试类型中,成品测试是最突出和最重要的部分。这是因为它直接影响最终分销给消费者的药品的品质、安全性和功效。 FDA 等监管机构要求对成品进行严格测试,以确保符合安全标准并确认其性能符合预期。随着製药公司努力满足这些监管要求,成品测试外包成为确保市场效率和可靠性的关键策略。

医药分析测试外包市场-地理洞察

北美医药分析测试外包市场正在稳步成长,受药物开发复杂性增加、成本优化需求以及测试技术进步等因素的推动。美国凭藉其强大的製药业、高昂的医疗保健支出和完善的监管框架在该地区占据主导地位。外包有助于公司管理成本、提高营运效率并获得分析测试的专业知识。此外,对生物製药和仿製药的需求不断增长,推动了市场扩张。

该地区的主要参与者包括提供从稳定性测试到品质控制等广泛服务的全球合约测试组织。随着监管标准日益严格,製药公司越来越依赖第三方服务来确保合规性并加快产品上市时间。由于製药公司和外包供应商之间的合作趋势日益增强,预计市场将继续成长。

美国是北美医药分析测试外包市场的主导国家。它拥有全球最大的製药产业,拥有许多领先的药品製造商和生技公司。该国先进的医疗保健基础设施、FDA 等监管机构以及对研发的高度重视推动了外包需求。美国製药公司经常求助于合约测试组织来满足监管要求并加快药物开发流程,从而进一步巩固其市场领导地位。

医药分析测试外包市场-竞争格局:

製药分析测试外包市场的竞争格局以全球合约研究组织(CRO)、专业测试实验室和大型製药服务提供者的混合为特征。 Labcorp Drug Development、Charles River Laboratories 和 Eurofins Scientific 等领导者凭藉其广泛的测试服务组合和广泛的地理覆盖范围占据市场主导地位。公司正专注于透过高级资料分析和自动化等技术创新来增强其服务产品,以保持竞争优势。

随着企业寻求扩大其能力并改善服务交付,策略合作、合併和收购变得非常常见。此外,法规遵循和处理复杂药物配方的能力也是关键的区别因素。规模较小且专注于特定领域的企业正在生物分析和专业测试服务领域中不断开拓新市场。对更快、更具成本效益的测试解决方案的需求正推动公司采用更有效率的流程,从而进一步加剧竞争。

最新动态:

2023 年 12 月,Agno Pharma 收购了 Lubrizol Particle Sciences Inc.。此次收购涵盖了 Particle Sciences Inc. 不可或缺的药品配方技术,包括宾州伯利恆的开发和製造基地。

2023年11月,Eurofins收购了Quasfar,以支援拉丁美洲的製药业,增强其研发能力,并在药品开发的早期阶段提供支援。

目录

第一章:医药分析测试外包市场概述

  • 研究范围
  • 市场估计年限

第二章:执行摘要

  • 市场片段
    • 医药分析测试外包市场片段(依服务类型)
    • 医药分析测试外包市场片段(依测试类型)
    • 医药分析测试外包市场片段(按最终用户)
    • 药品分析测试外包市场(按国家/地区)
    • 医药分析测试外包市场(按地区)
  • 竞争洞察

第三章:医药分析测试外包关键市场趋势

  • 医药分析测试外包市场驱动因素
    • 市场驱动因素的影响分析
  • 医药分析测试外包市场限制
    • 市场限制的影响分析
  • 医药分析测试外包市场机会
  • 医药分析测试外包市场未来趋势

第四章:产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章:医药分析测试外包市场:地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章:医药分析测试外包市场格局

  • 2024年医药分析测试外包市占率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章:医药分析测试外包市场-按服务类型

  • 概述
    • 按服务类型分類的细分市场占有率分析
    • 品质控制测试
    • 生物分析测试
    • 稳定性测试
    • 方法开发和验证
    • 监管测试
    • 微生物检测

第八章:医药分析测试外包市场-按测试类型

  • 概述
    • 按测试类型进行细分份额分析
    • 原料检测
    • 成品测试
    • 临床试验测试
    • 包装测试

第九章:医药分析测试外包市场-按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 製药公司
    • 生技公司
    • 合约研究组织(CRO)
    • 学术和研究机构
    • 政府和监管机构

第 10 章:医药分析测试外包市场-按地域

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美医药分析测试外包主要製造商
    • 北美市场规模及预测(按国家/地区)
    • 北美市场规模和预测(按服务类型)
    • 北美市场规模和预测(按测试类型)
    • 北美市场规模及预测(按最终用户)
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲药物分析测试外包主要製造商
    • 欧洲市场规模及预测(按国家/地区)
    • 欧洲市场规模和预测(按服务类型)
    • 欧洲市场规模和预测(按测试类型)
    • 欧洲市场规模及预测(按最终用户)
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区医药分析测试外包主要製造商
    • 亚太地区市场规模及预测(依国家)
    • 亚太地区市场规模及预测(依服务类型)
    • 亚太地区市场规模及预测(依测试类型)
    • 亚太市场规模及预测(依最终用户)
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲(LATAM)
    • 概述
    • 拉丁美洲药物分析测试外包主要製造商
    • 拉丁美洲市场规模及预测(按国家/地区)
    • 拉丁美洲市场规模及预测(按服务类型)
    • 拉丁美洲市场规模及预测(依测试类型)
    • 拉丁美洲市场规模及预测(按最终用户)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲(MEA)
    • 概述
    • 中东和非洲的药物分析测试外包主要製造商
    • MEA市场规模及预测(依国家)
    • MEA市场规模及预测(依服务类型)
    • MEA 市场规模及预测(依测试类型)
    • MEA 市场规模及预测(依最终用户)
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 11 章:关键供应商分析医药分析测试外包产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Labcorp Drug Development
    • Charles River Laboratories
    • WuXi AppTec
    • PPD (Pharmaceutical Product Development)
    • Eurofins Scientific
    • Intertek Group
    • Parexel International
    • Syneos Health
    • Catalent
    • Bioanalytical Systems, Inc. (BASi)
    • Patheon
    • Medpace
    • Pharmaceutical Product Development (PPD)
    • Aptuit
    • Toxikon
    • Frontage Laboratories
    • Covance
    • ICON plc

第 12 章:360 度分析师视角

第 13 章:附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4934

REPORT HIGHLIGHT

Pharmaceutical Analytical Testing Outsourcing Market size was valued at US$ 8,530.55 Million in 2024, expanding at a CAGR of 7.70% from 2025 to 2032.

The Pharmaceutical Analytical Testing Outsourcing Market refers to the growing trend of pharmaceutical companies outsourcing their analytical testing services to third-party organizations. These services involve testing the quality, safety, and efficacy of pharmaceutical products, including raw materials, formulations, and finished drugs. By outsourcing, companies can reduce operational costs, enhance efficiency, and access specialized expertise without investing heavily in in-house facilities. Key players in the market include contract research organizations (CROs) and independent testing labs. The market has seen growth due to increasing regulatory requirements, a rise in complex drug formulations, and a need for faster time-to-market. It also helps pharmaceutical companies manage resources effectively while maintaining high-quality standards. Global expansion and technological advancements are expected to drive further growth in this sector.

Pharmaceutical Analytical Testing Outsourcing Market- Market Dynamics

Expansion of generic drug markets boosting analytical testing needs

The expansion of the generic drug market is a significant driver for the pharmaceutical analytical testing outsourcing market. As the demand for affordable medications grows globally, particularly in North America, pharmaceutical companies increasingly focus on developing generic drugs, which requires stringent analytical testing to ensure quality and regulatory compliance. The generic drug industry benefits from lower production costs, and outsourcing analytical testing allows companies to maintain high standards while controlling expenses. Moreover, the increasing pressure to bring generics to market quickly further drives the need for outsourcing, as third-party testing providers offer speed and specialized expertise. According to the U.S. FDA, over 90% of prescriptions in the U.S. are filled with generics, highlighting the vast market size and the corresponding need for reliable and efficient testing. This trend is expected to continue, fueling demand for contract testing services in the coming years.

Pharmaceutical Analytical Testing Outsourcing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.70% over the forecast period (2025-2032)

Based on Service Type segmentation, Quality Control Testing was predicted to show maximum market share in the year 2024

Based on Testing Type segmentation, Finished Product Testing was the leading Testing Type in 2024

Based on End-User segmentation, Pharmaceutical Companies was the leading End-User in 2024

On the basis of region, North America was the leading revenue generator in 2024

Pharmaceutical Analytical Testing Outsourcing Market- Segmentation Analysis:

The Global Pharmaceutical Analytical Testing Outsourcing Market is segmented on the basis of Service Type, Testing Type, End-User, and Region.

The market is divided into six categories based on Service Type: Quality Control Testing, Bioanalytical Testing, Stability Testing, Method Development and Validation, Regulatory Testing, and Microbiological Testing. In the Pharmaceutical Analytical Testing Outsourcing Market, Quality Control Testing is the most significant and dominant segment. This is due to its critical role in ensuring that pharmaceutical products meet the required standards of safety, efficacy, and quality before they reach the market. Quality control testing is mandatory throughout the drug development process and is essential for regulatory compliance, which makes it a key focus for outsourcing in the pharmaceutical industry. The increasing demand for high-quality, reliable products drives a continuous need for these services, further solidifying its prominence.

The market is divided into four categories based on Testing Type: Raw Material Testing, Finished Product Testing, Clinical Trial Testing, and Packaging Testing. Among the testing types in the Pharmaceutical Analytical Testing Outsourcing Market, Finished Product Testing is the most prominent and significant segment. This is because it directly impacts the quality, safety, and efficacy of the final pharmaceutical products that are distributed to consumers. Regulatory agencies, such as the FDA, require stringent testing of finished products to ensure compliance with safety standards and to confirm that they perform as intended. As pharmaceutical companies strive to meet these regulatory requirements, outsourcing of finished product testing becomes a key strategy to ensure efficiency and reliability in the market.

Pharmaceutical Analytical Testing Outsourcing Market- Geographical Insights

The North American pharmaceutical analytical testing outsourcing market is growing steadily, driven by factors such as increasing drug development complexity, the need for cost optimization, and advancements in testing technologies. The U.S. dominates the region due to its robust pharmaceutical industry, high healthcare expenditures, and well-established regulatory frameworks. Outsourcing helps companies manage costs, improve operational efficiency, and gain access to specialized expertise in analytical testing. Further, the rising demand for biopharmaceuticals and generics fuels market expansion.

Key players in the region include global contract testing organizations offering a wide range of services, from stability testing to quality control. As regulatory standards become stricter, pharmaceutical companies increasingly rely on third-party services to ensure compliance and accelerate time-to-market. The market is expected to witness continued growth due to the increasing trend of partnerships between pharmaceutical companies and outsourcing providers.

The United States is the dominant country in the North American pharmaceutical analytical testing outsourcing market. It boasts the largest pharmaceutical industry globally, with numerous leading drug manufacturers and biotech firms. The country's advanced healthcare infrastructure, regulatory bodies like the FDA, and strong emphasis on research and development drive the demand for outsourcing. U.S.-based pharmaceutical companies often turn to contract testing organizations to meet regulatory requirements and expedite drug development processes, further solidifying its market leadership.

Pharmaceutical Analytical Testing Outsourcing Market- Competitive Landscape:

The competitive landscape of the Pharmaceutical Analytical Testing Outsourcing Market is characterized by a mix of global contract research organizations (CROs), specialized testing labs, and large pharmaceutical service providers. Leading players like Labcorp Drug Development, Charles River Laboratories, and Eurofins Scientific dominate the market with their extensive portfolios of testing services and a broad geographical reach. Companies are focusing on enhancing their service offerings through technological innovations, such as advanced data analytics and automation, to stay ahead of the competition.

Strategic collaborations, mergers, and acquisitions are common as firms seek to expand their capabilities and improve service delivery. Additionally, regulatory compliance and the ability to handle complex drug formulations are key differentiators. Smaller and niche players are increasingly carving out specialized niches in bioanalytical and specialized testing services. The demand for faster, cost-effective testing solutions is pushing companies to adopt more efficient processes, further intensifying competition.

Recent Developments:

In December 2023, Agno Pharma acquired Lubrizol Particle Sciences Inc. The acquisition encompasses the drug product formulation technology integral to Particle Sciences Inc. including the PA, Bethlehem development & manufacturing site.

In November 2023, Eurofins acquired Quasfar supporting the pharmaceutical industry in Latin America, enhancing its capabilities in R&D, and providing support in the early stages of pharmaceutical product development.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBALPHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Labcorp Drug Development
  • Charles River Laboratories
  • WuXi AppTec
  • PPD (Pharmaceutical Product Development)
  • Eurofins Scientific
  • Intertek Group
  • Parexel International
  • Syneos Health
  • Catalent
  • Bioanalytical Systems, Inc. (BASi)
  • Patheon
  • Medpace
  • Pharmaceutical Product Development (PPD)
  • Aptuit
  • Toxikon
  • Frontage Laboratories
  • Covance
  • ICON plc

GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Quality Control Testing
  • Bioanalytical Testing
  • Stability Testing
  • Method Development and Validation
  • Regulatory Testing
  • Microbiological Testing

GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY TESTING TYPE- MARKET ANALYSIS, 2019 - 2032

  • Raw Material Testing
  • Finished Product Testing
  • Clinical Trial Testing
  • Packaging Testing

GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes
  • Government and Regulatory Bodies

GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pharmaceutical Analytical Testing Outsourcing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pharmaceutical Analytical Testing Outsourcing Market Snippet by Service Type
    • 2.1.2. Pharmaceutical Analytical Testing Outsourcing Market Snippet by Testing Type
    • 2.1.3. Pharmaceutical Analytical Testing Outsourcing Market Snippet by End-User
    • 2.1.4. Pharmaceutical Analytical Testing Outsourcing Market Snippet by Country
    • 2.1.5. Pharmaceutical Analytical Testing Outsourcing Market Snippet by Region
  • 2.2. Competitive Insights

3. Pharmaceutical Analytical Testing Outsourcing Key Market Trends

  • 3.1. Pharmaceutical Analytical Testing Outsourcing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pharmaceutical Analytical Testing Outsourcing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pharmaceutical Analytical Testing Outsourcing Market Opportunities
  • 3.4. Pharmaceutical Analytical Testing Outsourcing Market Future Trends

4. Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pharmaceutical Analytical Testing Outsourcing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Pharmaceutical Analytical Testing Outsourcing Market Landscape

  • 6.1. Pharmaceutical Analytical Testing Outsourcing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pharmaceutical Analytical Testing Outsourcing Market - By Service Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Service Type, 2024 & 2032 (%)
    • 7.1.2. Quality Control Testing
    • 7.1.3. Bioanalytical Testing
    • 7.1.4. Stability Testing
    • 7.1.5. Method Development and Validation
    • 7.1.6. Regulatory Testing
    • 7.1.7. Microbiological Testing

8. Pharmaceutical Analytical Testing Outsourcing Market - By Testing Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Testing Type, 2024 & 2032 (%)
    • 8.1.2. Raw Material Testing
    • 8.1.3. Finished Product Testing
    • 8.1.4. Clinical Trial Testing
    • 8.1.5. Packaging Testing

9. Pharmaceutical Analytical Testing Outsourcing Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 9.1.2. Pharmaceutical Companies
    • 9.1.3. Biotechnology Companies
    • 9.1.4. Contract Research Organizations (CROs)
    • 9.1.5. Academic and Research Institutes
    • 9.1.6. Government and Regulatory Bodies

10. Pharmaceutical Analytical Testing Outsourcing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Pharmaceutical Analytical Testing Outsourcing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Pharmaceutical Analytical Testing Outsourcing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Pharmaceutical Analytical Testing Outsourcing Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APACMarket Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APACMarket Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
    • 10.4.6. APACMarket Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Pharmaceutical Analytical Testing Outsourcing Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAMMarket Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAMMarket Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Pharmaceutical Analytical Testing Outsourcing Key Manufacturers in Middle East and Africa
    • 10.6.3. MEAMarket Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEAMarket Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. IsraelMarket Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. IsraelMarket Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. IsraelMarket Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Pharmaceutical Analytical Testing Outsourcing Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Labcorp Drug Development
    • 11.2.2. Charles River Laboratories
    • 11.2.3. WuXi AppTec
    • 11.2.4. PPD (Pharmaceutical Product Development)
    • 11.2.5. Eurofins Scientific
    • 11.2.6. Intertek Group
    • 11.2.7. Parexel International
    • 11.2.8. Syneos Health
    • 11.2.9. Catalent
    • 11.2.10. Bioanalytical Systems, Inc. (BASi)
    • 11.2.11. Patheon
    • 11.2.12. Medpace
    • 11.2.13. Pharmaceutical Product Development (PPD)
    • 11.2.14. Aptuit
    • 11.2.15. Toxikon
    • 11.2.16. Frontage Laboratories
    • 11.2.17. Covance
    • 11.2.18. ICON plc

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us